Fact CheckerSign in

NCT04411303Active, not recruitingPhase 1

A Novel, Comprehensive Approach to Post-stroke Gait Rehabilitation

Source: ClinicalTrials.gov · Last updated 4 Nov 2025

Brief summary (registry, in English)

The goal of this project is to determine the feasibility and optimal parameters of a novel, comprehensive approach to gait training in individuals with chronic stroke. The comprehensive approach includes biofeedback-based gait training and aerobic exercise intensity-based gait training.

Status (registry)
Active, not recruiting
Phase (registry)
Phase 1
Study type
Interventional
Enrollment
50 (estimated)
First submitted
19 May 2020
Start date
9 Jun 2021
Primary completion date
14 Aug 2024
Lead sponsor
University of Southern California
Diseases
Stroke
NCT number
NCT04411303

What you commit to

  • Study type: Interventional · Phase 1
  • Planned participants: 50
  • From 9 Jun 2021 to the primary completion date, 14 Aug 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Uncontrolled hypertension (\>160/100mmHg)
  • Orthopedic or pain conditions
    • Note\*: Pregnant women are excluded from this study to avoid any potential harm to the fetus from the harness used during treadmill walking.

Other

  • Damage to the pons or cerebellum on MRI or signs of cerebellar involvement
  • Damage to the basal ganglia or extrapyramidal symptoms
  • Montreal Cognitive Assessment score \< 25

Who the study is looking for

  • \>6 months post stroke, affecting 1 hemisphere of the brain
  • Independently ambulatory (including use assistive devices)
  • Able to walk for 5 minutes without stopping
  • Demonstrates readiness for exercise based on responses to the PAR-Q+
  • Participants enrolled in Aim 2 will require medical clearance from physician to participate

Age in the registry: 18 years to 80 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
University of Southern California
Coordinator of this site? Confirm its status
Los AngelesUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.